ZERONDA TYLER (Interim CFO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2022ACC: 0001209191-22-033544
Officer· Interim CFO
Since Jun 2021
+12.51K
Net shares
Net buyer
$4.3K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
12.51K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.51K
Price / share
$0.35
Trade value
$4.33K
% of position
7.7%
5/31/2022
161.56K→174.07K
Total
Net shares
+12.51K
Net value
$4.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/31/2022 | A · Award | +12.51K | $0.35 | $4.33K | 7.7% | 161.56K | 174.07K |
| Total | +12.51K | $4.33K | ||||||
Derivative Transactions0
No derivative transactions reported